Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dr. Martens PLC Board/Management Information 2023

Jul 14, 2023

5055_mang_2023-07-14_96c915ce-bbc0-4935-b775-d3877efa8914.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 1223G

Dr. Martens PLC

14 July 2023

14 July 2023

Dr. Martens plc

Director Declaration

Pursuant to Listing Rule 9.6.14(2), Dr. Martens plc confirms that Jon Mortimore will be appointed to the Board of Dalata Hotel Group plc as a Non-Executive Director with effect from 1 August 2023.

ENDS

Enquiries:

Paul Rolling, Assistant Company Secretary             +4475 8424 3562

[email protected]

Bethany Barnes, Director of Investor Relations      +4478 2518 7465

[email protected]

About Dr. Martens plc:

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNZZLFFXDLFBBZ